Many thousands of devices have been used in acromioclavcular reconstruction over more than 15 years all over the world. This weight of clinical evidence combined with exceptional patient satisfaction means LockDown should be the technique of choice in both chronic and acute settings.
Building on the technology and clinical evidence of LSSS, LASS increases the stability of lateral and medial ankle ligaments in both acute and chronic cases with a simple and reproducible procedure.
You can be assured that with over 13 years of clinical use and 2,000+ devices implanted per year, the LockDown ACJ system has proven time and again to be the number one choice for surgeons in many countries worldwide.
LockDown are committed to providing educational content around our products. The weight of clinical evidence, both born out of and supplemented by our relationships with key opinion leaders around the world is presented here along with clinical presentations and (for Medical Professionals) videos revealing the nuances around our surgical techniques.